five

Safety and Efficacy Study of BMS-908662 Alone or in Combination With Cetuximab in Subjects With K-RAS or B-RAF Mutation Positive Advanced or Metastatic Colorectal Cancer

收藏
NIAID Data Ecosystem2026-03-06 收录
下载链接:
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2086270
下载链接
链接失效反馈
官方服务:
资源简介:
The purpose of the study is to identify a safe and tolerable dose of BMS-908662 in combination with cetuximab; and then to evaluate the tumor response to BMS-908662 when administered alone or in combination with cetuximab
创建时间:
2010-07-15
二维码
社区交流群
二维码
科研交流群
商业服务